NEPHROGENEX
NephroGenex is a drug-development company focusing on kidney disease. The Company is developing Pyridorinâ„¢ (pyridoxamine dihydrochloride) as a treatment to slow the progression of diabetic kidney disease.
NEPHROGENEX
Industry:
Biotechnology Diabetes Health Care
Founded:
2004-01-01
Address:
Princeton, New Jersey, United States
Country:
United States
Website Url:
http://www.nephrogenex.com
Total Employee:
11+
Status:
Active
Contact:
609-986-1780
Total Funding:
21.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API LetsEncrypt WordPress Domain Not Resolving Wordpress Plugins Euro Organization Schema
Similar Organizations
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
East West Bank
East West Bank investment in Post-IPO Equity - NephroGenex
Care Capital
Care Capital investment in Series A - NephroGenex
BioStratum
BioStratum investment in Series A - NephroGenex
Vanderbilt University Office of Investments
Vanderbilt University Office of Investments investment in Series A - NephroGenex
Official Site Inspections
http://www.nephrogenex.com
- Host name: 104.21.88.106
- IP address: 104.21.88.106
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "NephroGenex"
NephroGenex, Inc
NephroGenex is an innovator in the development of drugs to treat kidney disease, with a first indication in diabetic nephropathy. Our clinical and regulatory teams positioned the Phase 3 …See details»
Company Overviewcompany/ - nephrogenex.com
NephroGenex is applying the latest advances in molecular profiling technologies to unravel the complex pathologies found in kidney disease, and overcome long standing obstacles for drug …See details»
Management Team - nephrogenex.com
Pierre Legault joined NephroGenex in October 2013 as Chief Executive Officer and has been a member of the Company’s Board of Directors since November 2012. Mr. Legault formerly …See details»
Nephrogenex Inc. Company Profile | Raleigh, NC | Competitors ...
Find company research, competitor information, contact details & financial data for Nephrogenex Inc. of Raleigh, NC. Get the latest business insights from Dun & Bradstreet.See details»
NephroGenex Inc - Company Profile and News - Bloomberg Markets
NephroGenex, Inc. develops novel drugs for the treatment of kidney disease. The Company is developing a small molecule drug that acts as an inhibitor of the pathogenic oxidative …See details»
As funds dwindle, Bind Therapeutics, NephroGenex file for …
May 2, 2016 · Two biotech companies, Bind Therapeutics ($BIND) and NephroGenex ($NRX), are seeking the temporary protection of a Chapter 11 bankruptcy order as both look to a …See details»
NEPHROGENEX INC Company Profile | Cary, NC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for NEPHROGENEX INC of Cary, NC. Get the latest business insights from Dun & Bradstreet.See details»
NephroGenex - Overview, News & Similar companies - ZoomInfo
NephroGenex contact info: Phone number: (609) 986-1780 Website: www.nephrogenex.com What does NephroGenex do? NephroGenex Inc. is a pharmaceutical company which is …See details»
NephroGenex Files For Bankruptcy Protection Under Chapter 11
May 2, 2016 · NephroGenex, Inc. (Nasdaq: NRX) revealed it filed for a voluntary petition under Chapter 11 of the Bankruptcy Code in the Bankruptcy Court for the District of Delaware in the …See details»
NephroGenex, Inc. - VentureRadar
NephroGenex is developing pharmaceuticals against certain kidney diseases. ... Find out more about NephroGenex, Inc., Healthtech, Biotech, Biotechnology, Therapeutics, Healthtech and …See details»
NephroGenex - Funding, Financials, Valuation & Investors
NephroGenex is a drug-development company focusing on kidney disease and progression of diabetic kidney disease.See details»
Contact Us - nephrogenex.com
Address: NephroGenex Inc. 3200 Beechleaf Ct. Suite 900 Raleigh, NC 27604 (609) 986-1780See details»
NephroGenex Company Profile - Office Locations, Competitors
NephroGenex is a company operating an online store that provides customers with a range of medications. It offers oncology, endocrinology, gynecology, cardiology, ophthalmology, …See details»
NephroGenex, Inc. | Insights
May 2, 2016 · Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
NephroGenex - Contacts, Employees, Board Members, Advisors
NephroGenex is a drug-development company focusing on kidney disease and progression of diabetic kidney disease.See details»
NephroGenex CEO, Founder, Key Executive Team, Board of …
Explore {NephroGenex's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
NephroGenex sold assets to Medpace Research - Cassel Salpeter
May 1, 2017 · Background: NephroGenex, headquartered in Raleigh, NC, is a specialty pharmaceutical Company that focused on the development of therapeutics to treat kidney …See details»
NephroGenex begins Phase III trial of Pyridorin for diabetic kidney ...
Jun 18, 2014 · NephroGenex has started patient enrolment for the first of two pivotal Phase III studies in the PIONEER programme for oral Pyridorin, which is indicated for slow progression …See details»
Nephronex 900 mcg/5 mL oral liquid - Kaiser Permanente
This product is a combination of B vitamins used to treat or prevent vitamin deficiency due to poor diet, certain illnesses, alcoholism, or during pregnancy. Vitamins are important building blocks …See details»